BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21437770)

  • 1. Quantitative assessment of hypoxia subtypes in microcirculatory supply units of malignant tumors using (immuno-)fluorescence techniques.
    Maftei CA; Bayer C; Shi K; Astner ST; Vaupel P
    Strahlenther Onkol; 2011 Apr; 187(4):260-6. PubMed ID: 21437770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the fraction of total hypoxia and hypoxia subtypes in human squamous cell carcinomas upon fractionated irradiation: evaluation using pattern recognition in microcirculatory supply units.
    Maftei CA; Bayer C; Shi K; Astner ST; Vaupel P
    Radiother Oncol; 2011 Oct; 101(1):209-16. PubMed ID: 21641070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of (immuno-)fluorescence data with serial [¹⁸F]Fmiso PET/CT imaging for assessment of chronic and acute hypoxia in head and neck cancers.
    Maftei CA; Shi K; Bayer C; Astner ST; Vaupel P
    Radiother Oncol; 2011 Jun; 99(3):412-7. PubMed ID: 21719136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-localisation of hypoxia and perfusion markers with parameters of glucose metabolism in human squamous cell carcinoma (hSCC) xenografts.
    Yaromina A; Quennet V; Zips D; Meyer S; Shakirin G; Walenta S; Mueller-Klieser W; Baumann M
    Int J Radiat Biol; 2009 Nov; 85(11):972-80. PubMed ID: 19895274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-inducible factor pathway inhibition resolves tumor hypoxia and improves local tumor control after single-dose irradiation.
    Helbig L; Koi L; Brüchner K; Gurtner K; Hess-Stumpp H; Unterschemmann K; Pruschy M; Baumann M; Yaromina A; Zips D
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):159-66. PubMed ID: 24331663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis.
    Rijken PF; Bernsen HJ; Peters JP; Hodgkiss RJ; Raleigh JA; van der Kogel AJ
    Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):571-82. PubMed ID: 10974478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies.
    Yaromina A; Zips D; Thames HD; Eicheler W; Krause M; Rosner A; Haase M; Petersen C; Raleigh JA; Quennet V; Walenta S; Mueller-Klieser W; Baumann M
    Radiother Oncol; 2006 Nov; 81(2):122-9. PubMed ID: 16956683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion limited hypoxia estimated by vascular image analysis: comparison with pimonidazole staining in human tumors.
    Haustermans K; Hofland I; Van de Pavert L; Geboes K; Varia M; Raleigh J; Begg AC
    Radiother Oncol; 2000 Jun; 55(3):325-33. PubMed ID: 10869747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra- and intertumor heterogeneities in total, chronic, and acute hypoxia in xenografted squamous cell carcinomas. Detection and quantification using (immuno-)fluorescence techniques.
    Maftei CA; Bayer C; Shi K; Vaupel P
    Strahlenther Onkol; 2012 Jul; 188(7):606-15. PubMed ID: 22695745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring PAI-1 and VEGF levels in 6 human squamous cell carcinoma xenografts during fractionated irradiation.
    Bayer C; Kielow A; Schilling D; Maftei CA; Zips D; Yaromina A; Baumann M; Molls M; Multhoff G
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e409-17. PubMed ID: 22687194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation-associated staining with anti-pimonidazole antibodies in head and neck tumors.
    Janssen HL; Hoebers FJ; Sprong D; Goethals L; Williams KJ; Stratford IJ; Haustermans KM; Balm AJ; Begg AC
    Radiother Oncol; 2004 Jan; 70(1):91-7. PubMed ID: 15036858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays.
    Kennedy AS; Raleigh JA; Perez GM; Calkins DP; Thrall DE; Novotny DB; Varia MA
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):897-905. PubMed ID: 9128967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of nonproliferating but viable hypoxic tumor cells in vivo.
    Durand RE; Raleigh JA
    Cancer Res; 1998 Aug; 58(16):3547-50. PubMed ID: 9721858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors.
    Troost EG; Laverman P; Kaanders JH; Philippens M; Lok J; Oyen WJ; van der Kogel AJ; Boerman OC; Bussink J
    Radiother Oncol; 2006 Aug; 80(2):157-64. PubMed ID: 16905213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia and perfusion measurements in human tumors--initial experience with pimonidazole and IUdR.
    Begg AC; Janssen H; Sprong D; Hofland I; Blommestijn G; Raleigh JA; Varia M; Balm A; Van Velthuyzen L; Delaere P; Sciot R; Haustermans KMG
    Acta Oncol; 2001; 40(8):924-8. PubMed ID: 11845956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core needle biopsies for determination of the microenvironment in individual tumours for longitudinal radiobiological studies.
    Yaromina A; Eckardt A; Zips D; Eicheler W; Schuetze C; Thames H; Baumann M
    Radiother Oncol; 2009 Sep; 92(3):460-5. PubMed ID: 19682759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models.
    O'Donoghue JA; Zanzonico P; Pugachev A; Wen B; Smith-Jones P; Cai S; Burnazi E; Finn RD; Burgman P; Ruan S; Lewis JS; Welch MJ; Ling CC; Humm JL
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1493-502. PubMed ID: 15817355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of FMISO simulations with pimonidazole-stained tumor xenografts: A question of O2 consumption?
    Wack LJ; Mönnich D; Yaromina A; Zips D; Baumann M; Thorwarth D
    Med Phys; 2016 Jul; 43(7):4113. PubMed ID: 27370131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors.
    Janssen HL; Haustermans KM; Sprong D; Blommestijn G; Hofland I; Hoebers FJ; Blijweert E; Raleigh JA; Semenza GL; Varia MA; Balm AJ; van Velthuysen ML; Delaere P; Sciot R; Begg AC
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1537-49. PubMed ID: 12459383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of different methods of CAIX quantification in relation to hypoxia in three human head and neck tumor lines.
    Troost EG; Bussink J; Kaanders JH; van Eerd J; Peters JP; Rijken PF; Boerman OC; van der Kogel AJ
    Radiother Oncol; 2005 Aug; 76(2):194-9. PubMed ID: 16024110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.